Admin
Pagină nouă: Pagina dedicata companiei BioAtla, Inc. listata cu simbolul US.BCAB ==Descriere companie== BioAtla, Inc. (www.bioatla.com) is a clinical-stage biopharmaceutical company. The Company is focused on developing antibody-based therapeutics for the treatment of solid tumor cancer. Its product candidate includes BA3011, BA3021, BA3071. Its lead product candidate, BA3011, is a conditionally active biologics (CAB) antibody-drug conjugates (ADC) that targets AXL. its second product ca...